CRC patients with high STING expression exhibited increased intratumoral CD8+ T cell infiltration and less frequent lymphovascular invasion in the early stage of cancer and had longer overall and recurrence-free survival compared to CRC patients with low STING expression (124), which has also been confirmed by Yang et al. The gene discussed is CD8A; the disease is cancer.